Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Hajj, Aline
Obeid, Sahar
Sahyoun, Saria
Haddad, Chadia
Azar, Jocelyne
Rabbaa Khabbaz, Lydia
and
Hallit, Souheil
2019.
Clinical and Genetic Factors Associated with Resistance to Treatment in Patients with Schizophrenia: A Case-Control Study.
International Journal of Molecular Sciences,
Vol. 20,
Issue. 19,
p.
4753.
Sun, Ting
Zhao, Pengfei
Jiang, Xiaowei
Zhou, Yifang
Li, Chao
Jia, Linna
Tang, Yanqing
and
Liu, Zhifen
2020.
Distinct Associations of Cognitive Impairments and Reduced Gray Matter Volumes in Remitted Patients with Schizophrenia and Bipolar Disorder.
Neural Plasticity,
Vol. 2020,
Issue. ,
p.
1.
Maffioletti, Elisabetta
Valsecchi, Paolo
Minelli, Alessandra
Magri, Chiara
Bonvicini, Cristian
Barlati, Stefano
Sacchetti, Emilio
Vita, Antonio
and
Gennarelli, Massimo
2020.
Association study between HTR2A rs6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patients.
Drug Development Research,
Vol. 81,
Issue. 6,
p.
754.
Wu, Zhi Wei
Shi, Hui
Chen, Da Chun
Chen, Song
Xiu, Mei Hong
and
Zhang, Xiang Yang
2020.
BDNF serum levels and cognitive improvement in drug-naive first episode patients with schizophrenia: A prospective 12-week longitudinal study.
Psychoneuroendocrinology,
Vol. 122,
Issue. ,
p.
104879.
Lin, Chin-Chuen
and
Huang, Tiao-Lai
2020.
Brain-derived neurotrophic factor and mental disorders.
Biomedical Journal,
Vol. 43,
Issue. 2,
p.
134.
Wang, Wenchen
Liu, Yuanyuan
Luo, Shuqing
Guo, Xiaoyun
Luo, Xingguang
and
Zhang, Yong
2020.
Associations between brain‐derived neurotrophic factor and cognitive impairment in panic disorder.
Brain and Behavior,
Vol. 10,
Issue. 12,
Yin, Fangna
Wang, Hongbing
Liu, Zeya
and
Gao, Junwei
2020.
Association between peripheral blood levels of C-reactive protein and Autism Spectrum Disorder in children: A systematic review and meta-analysis.
Brain, Behavior, and Immunity,
Vol. 88,
Issue. ,
p.
432.
Barnes-Scheufler, Catherine V.
Passow, Caroline
Rösler, Lara
Mayer, Jutta S.
Oertel, Viola
Kittel-Schneider, Sarah
Matura, Silke
Reif, Andreas
and
Bittner, Robert A.
2021.
Transdiagnostic comparison of visual working memory capacity in bipolar disorder and schizophrenia.
International Journal of Bipolar Disorders,
Vol. 9,
Issue. 1,
North, Hayley F.
Bruggemann, Jason
Cropley, Vanessa
Swaminathan, Vaidy
Sundram, Suresh
Lenroot, Rhoshel
Pereira, Avril M.
Zalesky, Andrew
Bousman, Chad
Pantelis, Christos
Weickert, Thomas W.
and
Shannon Weickert, Cynthia
2021.
Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions.
European Archives of Psychiatry and Clinical Neuroscience,
Vol. 271,
Issue. 4,
p.
595.
Sagud, Marina
Nikolac Perkovic, Matea
Dvojkovic, Anja
Jaksic, Nenad
Vuksan-Cusa, Bjanka
Zivkovic, Maja
Kusevic, Zorana
Mihaljevic-Peles, Alma
and
Pivac, Nela
2021.
Distinct association of plasma BDNF concentration and cognitive function in depressed patients treated with vortioxetine or escitalopram.
Psychopharmacology,
Vol. 238,
Issue. 6,
p.
1575.
Yang, Haidong
Xiao, Wenhuan
Yang, Man
Wang, Yili
and
Zhang, Xiaobin
2021.
Decreased neuregulin1β1 in first episode and drug-naïve patients with schizophrenia: Negative correlation with cognitive impairment.
Psychiatry Research,
Vol. 304,
Issue. ,
p.
114164.
Bora, Emre
2021.
Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysis — CORRIGENDUM.
Psychological Medicine,
Vol. 51,
Issue. 9,
p.
1589.
Martínez, Antón L.
Brea, José
Rico, Sara
de los Frailes, María Teresa
and
Loza, María Isabel
2021.
Cognitive Deficit in Schizophrenia: From Etiology to Novel Treatments.
International Journal of Molecular Sciences,
Vol. 22,
Issue. 18,
p.
9905.
Su, Xiuru
Qiao, Limin
Liu, Qing
Shang, Yujie
Guan, Xiaoni
Xiu, Meihong
and
Zhang, Xiangyang
2021.
Genetic polymorphisms of BDNF on cognitive functions in drug-naive first episode patients with schizophrenia.
Scientific Reports,
Vol. 11,
Issue. 1,
Nieto, Rodrigo R.
Carrasco, Andrea
Corral, Sebastian
Castillo, Rolando
Gaspar, Pablo A.
Bustamante, M. Leonor
and
Silva, Hernan
2021.
BDNF as a Biomarker of Cognition in Schizophrenia/Psychosis: An Updated Review.
Frontiers in Psychiatry,
Vol. 12,
Issue. ,
Ma, Mengying
Zhang, Yuyanan
Zhang, Xiao
Yan, Hao
Zhang, Dai
and
Yue, Weihua
2021.
Common and Distinct Alterations of Cognitive Function and Brain Structure in Schizophrenia and Major Depressive Disorder: A Pilot Study.
Frontiers in Psychiatry,
Vol. 12,
Issue. ,
Liu, Ruimei
Tang, Wei
Wang, Weiping
Xu, Feikang
Fan, Weixing
Zhang, Yi
and
Zhang, Chen
2021.
NLRP3 Influences Cognitive Function in Schizophrenia in Han Chinese.
Frontiers in Genetics,
Vol. 12,
Issue. ,
Han, Dongmei
Sun, Daliang
Xiu, Meihong
Su, Xiu
Wang, Jun
Li, Jun
and
Wang, Dong
2021.
Association between the improvement in depressive symptoms and serum BDNF levels in drug-naive first episode patients with schizophrenia: A longitudinal follow-up.
Psychoneuroendocrinology,
Vol. 133,
Issue. ,
p.
105392.
Li, Chao
Shi, Zhenchun
Ji, Jiacui
Niu, Gengyun
and
Liu, Zengxun
2021.
Associations of C-Reactive Protein, Free Triiodothyronine, Thyroid Stimulating Hormone and Creatinine Levels with Agitation in Patients with Schizophrenia: A Comparative Cross-Sectional Study.
Neuropsychiatric Disease and Treatment,
Vol. Volume 17,
Issue. ,
p.
2575.
Teng, Ziwei
Wang, Lu
Li, Sujuan
Tan, Yuxi
Qiu, Yan
Wu, Chujun
Jin, Kun
Chen, Jindong
Huang, Jing
Tang, Hui
Xiang, Hui
Wang, Bolun
Yuan, Hui
and
Wu, Haishan
2021.
Low BDNF levels in serum are associated with cognitive impairments in medication-naïve patients with current depressive episode in BD II and MDD.
Journal of Affective Disorders,
Vol. 293,
Issue. ,
p.
90.